Skip to main content

and
  1. Article

    Open Access

    A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder

    Genome-wide association studies (GWASs) have identified several susceptibility loci for bipolar disorder (BD) and shown that the genetic architecture of BD can be explained by polygenicity, with numerous varia...

    M Ikeda, A Takahashi, Y Kamatani, Y Okahisa, H Kunugi, N Mori in Molecular Psychiatry (2018)

  2. No Access

    Article

    Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder

    Association between response to antidepressant treatment and genetic polymorphisms was examined in two independent Japanese samples of patients with major depressive disorder (MDD). Genome-wide approach using ...

    D Sasayama, A Hiraishi, M Tatsumi, K Kamijima, M Ikeda in The Pharmacogenomics Journal (2013)

  3. Article

    Open Access

    13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients

    Phenylalanine is an essential amino acid required for the synthesis of catecholamines including dopamine. Altered levels of phenylalanine and its metabolites in blood and cerebrospinal fluid have been reported...

    T Teraishi, Y Ozeki, H Hori, D Sasayama, S Chiba, N Yamamoto in Translational Psychiatry (2012)

  4. No Access

    Article

    Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders

    We investigated the plasma levels of VEGF and FGF-2, important factors for regulation of neuroplasticity such as neurogenesis, in patients in remission from major depressive disorders (MDD). The plasma VEGF le...

    M. Takebayashi, R. Hashimoto, K. Hisaoka, M. Tsuchioka in Journal of Neural Transmission (2010)

  5. No Access

    Article

    Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia

    Pituitary adenylate cyclase-activating polypeptide (PACAP, ADCYAP1: adenylate cyclase-activating polypeptide 1), a neuropeptide with neurotransmission modulating activity, is a promising schizophrenia candidat...

    R Hashimoto, H Hashimoto, N Shintani, S Chiba, S Hattori, T Okada in Molecular Psychiatry (2007)

  6. No Access

    Article

    The possible association between epigenetic aberration in DNA methylation in RELN and psychiatric disorders

    Y Tamura, H Kunugi, J Ohashi, H Hohjoh in Molecular Psychiatry (2007)

  7. No Access

    Article

    Epigenetic aberration of the human REELIN gene in psychiatric disorders

    Epigenetic genome modifications such as DNA methylation appear to be involved in various diseases. Here, we suggest that the levels of DNA methylation at the BssHII methylation-sensitive restriction enzyme sites ...

    Y Tamura, H Kunugi, J Ohashi, H Hohjoh in Molecular Psychiatry (2007)

  8. No Access

    Article

    Possible association between nonsynonymous polymorphisms of the anaplastic lymphoma kinase (ALK) gene and schizophrenia in a Japanese population

    We examined, for the first time, the possible association between schizophrenia and the anaplastic lymphoma kinase (ALK) gene which plays an important role in neurodevelopment. When two nonsynonymous polymorph...

    H. Kunugi, R. Hashimoto, T. Okada, H. Hori in Journal of Neural Transmission (2006)

  9. No Access

    Article

    Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus

    Altered expression of Disrupted-In-Schizophrenia-1 (DISC1) and dysbindin (DTNBP1), susceptibility genes for schizophrenia, in schizophrenic brain has been reported; however, the possible effect of antipsychoti...

    S. Chiba, R. Hashimoto, S. Hattori, M. Yohda, B. Lipska in Journal of Neural Transmission (2006)

  10. No Access

    Article

    A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity

    Previous studies have suggested that genetic variations in the brain-derived neurotrophic factor (BDNF) gene may be associated with several neuropsychiatric diseases including bipolar disorder. The present stu...

    T Okada, R Hashimoto, T Numakawa, Y Iijima, A Kosuga, M Tatsumi in Molecular Psychiatry (2006)

  11. No Access

    Article

    Association study of the frizzled-3 (FZD3) gene with schizophrenia and mood disorders

    Two research groups have recently reported a significant association between schizophrenia and genetic variants of Frizzled-3 (FZD3) gene. We examined a possible association in a Japanese sample of schizophren...

    R. Hashimoto, T. Suzuki, N. Iwata, Y. Yamanouchi in Journal of Neural Transmission (2005)

  12. No Access

    Article

    Association analysis of the −308G > A promoter polymorphism of the tumor necrosis factor alpha (TNF-α) gene in Japanese patients with schizophrenia

    Two research groups have thus far reported a significant association between schizophrenia and a promoter polymorphism (−308G > A) of the gene encoding tumor necrosis factor alpha (TNF-α), while contradictive ...

    R. Hashimoto, M. Yoshida, N. Ozaki, Y. Yamanouchi in Journal of Neural Transmission (2004)

  13. No Access

    Article

    Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders

    Alterations of G proteins have been implicated in major psychiatric illnesses. A C825T polymorphism of a gene encoding the β3 subunit of heterotrimeric G proteins (GNB3) was reported to be associated with sev...

    H. Kunugi, T. Kato, R. Fukuda, M. Tatsumi, T. Sakai in Journal of Neural Transmission (2002)

  14. No Access

    Article

    Exon/intron boundaries, novel polymorphisms, and association analysis with schizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene

    The synaptic vesicular monoamine transporter (SVMT), alternatively vesicular monoamine transporter 2 (VMAT2), pumps cytosolic monoamines including dopamine, norepinephrine, serotonin, and histamine into synapt...

    H Kunugi, S Ishida, A Akahane, S Nanko in Molecular Psychiatry (2001)

  15. No Access

    Article

    A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease

    Several lines of evidence have suggested altered functions of the brain-derived neurotrophic factor (BDNF) in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD). In the search fo...

    H Kunugi, A Ueki, M Otsuka, K Isse, H Hirasawa, N Kato, T Nabika in Molecular Psychiatry (2001)

  16. No Access

    Article

    No evidence for an association between the Glu298Asp polymorphism of the NOS3 gene and Alzheimer's disease

    Recently a significant association of a missense mutation (Glu298Asp) of the endothelial nitric oxide synthase (NOS3) gene with late-onset Alzheimer's disease (LOAD) was reported. We tried to replicate this f...

    H. Kunugi, A. Akahane, A. Ueki, M. Otsuka, K. Isse in Journal of Neural Transmission (2000)

  17. No Access

    Article

    A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders

    A polymorphism of a variable number tandem repeat (VNTR), that was recently found in the promoter region of the monoamine oxidase-A (MAOA) gene, was shown to be associated with its transcriptional activity. Th...

    H Kunugi, S Ishida, T Kato, M Tatsumi, T Sakai, M Hattori, T Hirose in Molecular Psychiatry (1999)

  18. No Access

    Article

    C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses

    A common missense mutation of the methylenetetrahydrofolate reductase (MTHFR) gene (C677T) has been shown to be a risk factor for premature cardiovascular disease and neural tube defect. Deficient activity of ...

    H Kunugi, R Fukuda, M Hattori, T Kato, M Tatsumi, T Sakai, T Hirose in Molecular Psychiatry (1998)

  19. No Access

    Article

    Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder

    Catechol-O-methyltransferase (COMT) plays a major role in the breakdown of catecholamines.1 An amino acid polymorphism (val-108-met) determines high and low activity of the enzyme.2,3 A recent study in a small sa...

    G Kirov, K C Murphy, M J Arranz, I Jones, F McCandles, H Kunugi in Molecular Psychiatry (1998)

  20. No Access

    Article

    Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder

    There is some evidence suggesting that a polymorphism of variable number of tandem repeats (VNTR) in the second intron of the serotonin transporter (5-HTT) gene and another variation which lies 1.2 kb upstream...

    H Kunugi, M Hattori, T Kato, M Tatsumi, T Sakai, T Sasaki, T Hirose in Molecular Psychiatry (1997)